AL
Lathuilière, Aurélien
Affiliation entities
Research groups
| Title | Published in | Access level | OA Policy | Year | Views | Downloads | |
|---|---|---|---|---|---|---|---|
| Utility of the Amygdalar Atrophy Scale to Identify Patients With Limbic-Predominant Age-Related TDP-43 Encephalopathy in a Memory Clinic | Neurology | 2026 | 4 | 4 | |||
| Stools from a human APOEe2 donor reduces amyloid and tau pathology and increases neuroinflammation in a 3xTg AD mouse model | Frontiers in aging neuroscience | 2025 | 134 | 208 | |||
| TSPO contributes to neuropathology and cognitive deficits in Alzheimer’s disease | Journal of neuroinflammation | 2025 | 36 | 23 | |||
| Fecal Microbiota Transplantation ( FMT ) From a Human at Low Risk for Alzheimer's Disease Improves Short‐Term Recognition Memory and Increases Neuroinflammation in a 3xTg AD Mouse Model | Genes, brain and behavior | 2025 | 101 | 72 | |||
| Head-to-head study of diagnostic accuracy of plasma and cerebrospinal fluid p-tau217 versus p-tau181 and p-tau231 in a memory clinic cohort | Journal of neurology | 2024 | 117 | 58 | |||
| Comparison of plasma and neuroimaging biomarkers to predict cognitive decline in non-demented memory clinic patients | Alzheimer's research & therapy | 2024 | 156 | 168 | |||
| Propagation of the tau protein in the brain: molecular mechanisms and clinical relevance | 2024 | 172 | 359 | ||||
| Alzheimer-Krankheit – Systembereitschaft im Kontext neuer Entwicklungen | Praxis | 2024 | 58 | 205 | |||
| SORL1 is a receptor for tau that promotes tau seeding | The Journal of biological chemistry | 2024 | 66 | 135 | |||
| Maladie d’Alzheimer : ce qui a changé en 2023 | Revue médicale suisse | 2024 | 127 | 58 | |||
| Engineering a versatile and retrievable cell macroencapsulation device for the delivery of therapeutic proteins | iScience | 2023 | 103 | 68 | |||
| Plasma biomarkers for Alzheimer's disease: a field-test in a memory clinic | Journal of neurology, neurosurgery and psychiatry | 2023 | 272 | 228 | |||
| Specific detection of tau seeding activity in Alzheimer's disease using rationally designed biosensor cells | Molecular neurodegeneration | 2023 | 96 | 254 | |||
| Sustained delivery of low-dose anti-CTLA-4 by genetically engineered encapsulated cells to the tumor microenvironment drives tumor response and prolongs survival in a colorectal cancer model | AACR Annual Meeting 2023 | 2023 | 79 | 176 | |||
| Metabolic network alterations as a supportive biomarker in dementia with Lewy bodies with preserved dopamine transmission | European journal of nuclear medicine and molecular imaging | 2023 | 111 | 41 | |||
| From patients to disease: the difficult case of Alzheimer's | Lancet neurology | 2022 | 368 | 1 | |||
| Immortalised human myoblast cell lines for the delivery of therapeutic proteins using encapsulated cell technology | Molecular therapy. Methods & clinical development | 2022 | 249 | 167 | |||
| Quantitative Methods for the Detection of Tau Seeding Activity in Human Biofluids | Frontiers in neuroscience | 2021 | 187 | 193 | |||
| Regulation of tau internalization, degradation, and seeding by LRP1 reveals multiple pathways for tau catabolism | Journal of Biological Chemistry | 2021 | 224 | 450 | |||
| Tau molecular diversity contributes to clinical heterogeneity in Alzheimer's disease | Nature medicine | 2020 | 196 | 1 | |||
| Prise en charge nutritionnelle du sujet âgé en neuro-réadaptation | Revue médicale suisse | 2019 | 526 | 307 | |||
| How to Prevent Loss of Muscle Mass and Strength among Older People in Neuro-Rehabilitation? | Nutrients | 2019 | 218 | 156 | |||
| Un implant bioactif pour prévenir la maladie d'Alzheimer | MS Médecine sciences | 2017 | 206 | 91 | |||
| Motifs in the tau protein that control binding to microtubules and aggregation determine pathological effects | Scientific reports | 2017 | 166 | 151 | |||
| Amyloid-β plaque deposition measured using propagation-based X-ray phase contrast CT imaging | Journal of synchrotron radiation | 2016 | 164 | 100 | |||
| A subcutaneous cellular implant for passive immunization against amyloid-β reduces brain amyloid and tau pathologies | Brain | 2016 | 274 | 107 | |||
| Lentiviral Vectors for the Engineering of Implantable Cells Secreting Recombinant Antibodies | Lentiviral Vectors and Exosomes as Gene and Protein Delivery Tools | 2016 | 173 | 0 | |||
| Encapsulated cellular implants for recombinant protein delivery and therapeutic modulation of the immune system | International journal of molecular sciences | 2015 | 214 | 200 | |||
| A high-capacity cell macroencapsulation system supporting the long-term survival of genetically engineered allogeneic cells | Biomaterials | 2014 | 176 | 1 | |||
| Genetic engineering of cell lines using lentiviral vectors to achieve antibody secretion following encapsulated implantation | Biomaterials | 2014 | 211 | 0 | |||
| Clusterin expression during fetal and postnatal CNS development in mouse | Neuroscience | 2008 | 703 | 0 | |||
| Cell death pathways differ in several mouse models with motoneurone disease: analysis of pure motoneurone populations at a presymptomatic age | Journal of neurochemistry | 2006 | 174 | 1 |
